Stay updated on Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision labels updated from v3.3.3 to v3.3.4 on the page, with no changes to study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T12:00:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Publication citation for the CheckMate 214 study was updated: a Lancet Oncology 2019 article entry was added with an erratum, and the previous version was removed.
    Difference
    0.0%
    Check dated 2026-01-09T05:51:15.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Expanded the Locations section with numerous new study sites across the US and internationally.
    Difference
    3%
    Check dated 2025-12-18T21:49:13.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The Publications section note was revised to indicate that publications are automatically filled from PubMed. The revision tag was updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-27T03:06:20.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    An administrative funding banner was removed from the page. The core study details and data remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-19T22:09:56.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Administrative updates were made to study record dates and the last verified timestamp. The core interventions, outcomes, and eligibility criteria remain unchanged.
    Difference
    0.1%
    Check dated 2025-10-29T10:05:39.000Z thumbnail image

Stay in the know with updates to Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.